60 Degrees Pharma shareholders approve 1:5-1:12 reverse split and 5M share increase

60 DEGREES PHARMACEUTICALS, INC.

All five director nominees elected; each received >3.6M votes for.
Amendment to 2022 Equity Plan approved: 5M new shares authorized for issuance.
Reverse stock split authorized at ratio between 1:5 to 1:12, effective date to be set by board.
Modification of CEO/CFO option strike price and consultant option issuance both approved to comply with Nasdaq listing rules.
Ratification of RBSM LLP as independent auditor for FY2024 approved with 6.2M votes for.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.